| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 From the Departments of Ophthalmology and Neuroscience, and the 2 Department of Molecular Biology and Genetics, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
PURPOSE. To determine the relative level and localization of bone morphogenetic protein (BMP)-4 mRNA in the retina and retinal pigmented epithelium (RPE) under normal and pathologic conditions, to seek clues regarding possible functions.
METHODS. Clones isolated from an RPE cDNA library were sequenced and used as probes for northern blot analysis. Expression in the retina and RPE was investigated in mouse models using reverse transcription–polymerase chain reaction (RT-PCR) and in situ hybridization. The effect of recombinant proteins on RPE proliferation was investigated by thymidine incorporation.
RESULTS. Bovine clones with high homology to BMP-2 and BMP-4 were isolated from a subtracted RPE cDNA library. Northern blot analysis using the clones as probes demonstrated abundant and differential expression in adult bovine RPE, but with RT-PCR and in situ hybridization, expression was also demonstrated in mouse retinal neurons. In mice with oxygen-induced ischemic retinopathy there was a striking decrease in BMP-4 mRNA in the retina within 6 hours of the onset of hypoxia that was maintained for at least 5 days. In mice with inherited photoreceptor degeneration, there was a dramatic decrease in BMP-4 mRNA in retina and RPE during and after the degeneration. mRNA for the type II BMP receptor was observed in freshly isolated and cultured RPE cells, isolated retina, and freshly isolated bovine aortic endothelial cells. Thymidine incorporation in early-passage RPE cells showed a 14-fold stimulation above control with 5% serum that was decreased to 322%, 393%, and 313% in the presence of BMP-2 (10 ng/ml), BMP-4 (10 ng/ml), and transforming growth factor (TGF)-ß1 (2 ng/ml), respectively.
CONCLUSIONS. BMP-2 and BMP-4 may serve as negative growth regulators in the retina and RPE that are downregulated by injury, to allow tissue repair. Modulation of expression of the BMPs may provide a means to control the exaggerated wound repair that occurs in proliferative retinopathies.
This article has been cited by other articles:
|
|
 |
|
  H. Lee, S. J. O'Meara, C. O'Brien, and R. Kane The Role of Gremlin, a BMP Antagonist, and Epithelial-to-Mesenchymal Transition in Proliferative Vitreoretinopathy Invest. Ophthalmol. Vis. Sci., September 1, 2007; 48(9): 4291 - 4299. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Wordinger and A. F. Clark Bone Morphogenetic Proteins and Their Receptors in the Eye Experimental Biology and Medicine, September 1, 2007; 232(8): 979 - 992. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. McGlinn, D. A. Baldwin, J. W. Tobias, M. T. Budak, T. S. Khurana, and R. A. Stone Form-Deprivation Myopia in Chick Induces Limited Changes in Retinal Gene Expression Invest. Ophthalmol. Vis. Sci., August 1, 2007; 48(8): 3430 - 3436. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Sehgal, D. J. Andres, R. Adler, and T. L. Belecky-Adams Bone morphogenetic protein 7 increases chick photoreceptor outer segment initiation. Invest. Ophthalmol. Vis. Sci., August 1, 2006; 47(8): 3625 - 3634. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R Kane, L Stevenson, C Godson, A W Stitt, and C O'Brien Gremlin gene expression in bovine retinal pericytes exposed to elevated glucose Br. J. Ophthalmol., December 1, 2005; 89(12): 1638 - 1642. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Yu, S. He, J. S. Friedman, M. Akimoto, D. Ghosh, A. J. Mears, D. Hicks, and A. Swaroop Altered Expression of Genes of the Bmp/Smad and Wnt/Calcium Signaling Pathways in the Cone-only Nrl-/- Mouse Retina, Revealed by Gene Profiling Using Custom cDNA Microarrays J. Biol. Chem., October 1, 2004; 279(40): 42211 - 42220. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. M. Langenfeld, S. E. Calvano, F. Abou-Nukta, S. F. Lowry, P. Amenta, and J. Langenfeld The mature bone morphogenetic protein-2 is aberrantly expressed in non-small cell lung carcinomas and stimulates tumor growth of A549 cells Carcinogenesis, September 1, 2003; 24(9): 1445 - 1454. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. L. Belecky-Adams, R. Adler, and D. C. Beebe Bone morphogenetic protein signaling and the initiation of lens fiber cell differentiation Development, March 10, 2003; 129(16): 3795 - 3802. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. U. Mysorekar, M. A. Mulvey, S. J. Hultgren, and J. I. Gordon Molecular Regulation of Urothelial Renewal and Host Defenses during Infection with Uropathogenic Escherichia coli J. Biol. Chem., February 22, 2002; 277(9): 7412 - 7419. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
